



Schwetz's editorial, "Responding to
Environmental Issues: Lessons Learned" (1),
was stimulating and raised many pertinent
points concerning the current interface of
politics with the scientific process. I would
like to discuss two issues raised by Schwetz.
First, Schwetz (1) noted that effort should
have been expended over the past few years
to build a database with which to evaluate
how endocrine-disrupting (ED) agents may
cause adverse effects in animals and
humans. Later, he stated that we still do not
have validated test methods for the detec-
tion ofendocrine-disrupting activity. These
two statements are in apparent conflict,
given that ED assays would be required to
establish a database. However, there are
many reliable ED assays in current use, and
all that is needed in many cases is agreement
on key aspects ofthe test protocols and lim-
itations on data extrapolation. The picture
is farfrom gloomy.
Second, Schwetz observed that
As the issue gained momentum, many scientists
who were active in ED-related research segregat-
ed into camps focused on discrediting the results
ofother researchers.
The single supporting reference for this
statement was a study by Cagen et al. (2),
who reported their inability to confirm
low-dose ED effects for bisphenol A (BPA)
on the CF-1 mouse prostate gland. We too
have been unable to reproduce some
recently published studies. These include
our failure to reproduce the low-dose ED
effects of the following: a) butyl benzyl
phthalate in the rat (3), as originally report-
ed by Sharpe et al. (4); b) BPA in the CF-1
mouse (5), as originally reported by Nagel
et al. (6); and c) nonylphenol in the Noble
rat (7, as originally reported by Colerangle
and Roy (8). The stimulus for the repeat
studies was not to discredit the work of
others, but to establish a model of these
unexpected low-dose ED effects in our own
laboratory in order to study their mecha-
nisms of action and to derive extended
dose-response relationships. In each case,
the model could not be established; given
the cost and time involved, that was disap-
pointing. In our papers describing those
studies (3,5,7), we were respectful of the
original investigators, and we emphasized
the possible inadequacies ofour own work.
It is critical to confirm independently at
least some ofthe recently reported low-dose
ED effects, and although science thrives on
debate, that debate must be considered and
leavened by new data. In particular, the
more unexpected a new ED effect is, the
greater the need for it to be described pre-
cisely with the aid ofraw data and for it to
be confirmed before publication. The study
ofendocrine disruption has had an imper-
fect start over the past few years, but the
topic demands attention. We should now
work to resolve the major outstanding
issues identified by Schwetz (1).
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